As per FMI Analysts, the global market is estimated to be valued at US$ 648.7 million in 2023. The overall market is projected to increase at a CAGR of 9.9% during the forecast period from 2023 to 2033. The global ischemic stroke aspiration systems market size is expected to reach US$ 1,672.8 million by 2033.
The market is growing rapidly, thanks to the increasing demand from hospitals and clinics. Further, the increasing prevalence of cardiovascular diseases and diabetes across the world is expected to drive market growth.
The key trend observed in the concerned market is the releases and approvals by key players to launch new products, thereby creating opportunities in the product market. This is expected to create a positive impact on the growth of the market in the coming years.
The lack of competent laboratory experts is hampering the expansion of the market. This is because as diagnostic laboratories deploy advanced ischemic stroke aspiration systems and automate processes, the expansion of diagnostic laboratories is also limited by a scarcity of skilled professionals.
The number of new graduates from clinical laboratory programs is decreasing, limiting the rapid expansion of the forum although the demand for ischemic stroke aspiration systems is rising. Also, the decreasing number of graduates is because clinical laboratory programs are being replaced by molecular biology and genetic programs. The market for ischemic stroke aspiration systems is projected to experience gradual growth during the forecast period due to increasing regional product penetration.
The Middle East and Africa are expected to be the least lucrative for the market due to the prevalent acceptance of ischemic stroke aspiration systems in the region.
| Report Attributes or Data Points | Details |
|---|---|
| Global Ischemic Stroke Aspiration Systems Market Valuation in 2022 | US$ 595.3 million |
| Estimated Global Market Share in 2023 | US$ 648.7 million |
| Forecasted Global Market Size by 2033 | US$ 1,672.8 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 9.9% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 8.7% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market has received a lot of traction in the industry in the last two decades. The increasing prevalence of cardiovascular diseases and diabetes across the world is expected to drive the propulsion in the market. Also, the key trend observed in the forum is the launches and approvals by key players to introduce new products, thereby creating key opportunities for market growth.
The market is growing significantly due to increasing product penetration in developing countries such as China and India. This is allowing manufacturers to generate revenue rapidly and drive growth.
Various global manufacturers in the market are looking for regional players for collaboration, partnership, and acquisition to expand their regional product footprint, which is expected to boost the sale of the product. In addition, increasing awareness about the possible symptoms of ischemic stroke resulting in improving treatment-seeking rates is fueling the usage of ischemic stroke aspiration systems.
| Category | By End User |
|---|---|
| Top Segment | Hospitals |
| Market Share in Percentage | 52.6% |
The overall market size is projected to be restrained by the factors such as the lack of skilled professionals and the high cost of equipment despite all of the potential growth opportunities. Moreover, the increased consumption of alcohol, smoking, and decreased physical activity that comes with a changed lifestyle can lead to an increased risk of ischemic stroke. However, the high cost of procedures may hamper the propulsion of the market.
A key obstacle that is expected to hamper market growth is the lack of competent laboratory experts. This is because as diagnostic laboratories deploy advanced ischemic stroke aspiration systems and automate processes, the expansion of diagnostic laboratories is also limited by a scarcity of skilled professionals.
The number of new graduates from clinical laboratory programs is decreasing although the demand for medical laboratory professionals is rising limiting the market growth. Moreover, the decreasing number of graduates is because clinical laboratory programs are being replaced by molecular biology and genetic programs.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 34.4% |
| Europe | 32.7% |
Principal Consultant
In terms of volume, North America is predicted to grow notably over the projection period. Due to the higher number of procedures carried out there, the North America region is expected to generate significant growth in the global market.
The market opportunities in Latin America are expected to see gradual growth by the end of the forecast period due to increasing product penetration, despite steady declining growth in the past few years.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| The United States | 31.8% |
| Germany | 8.8% |
| Japan | 4.7% |
Europe's market is expected to be the second leading market because the number of ischemic stroke aspiration systems for controlling ischemic strokes has increased steadily in recent years. Further, a significantly improving healthcare infrastructure is driving the notable growth of the Asia Pacific region and is expected to make the region one of the significantly growing regions throughout the forecast period.
The forum is expected to be the least leading market in the global market in the Middle East and Africa as it is anticipated as the least adopted product in this region.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| The United Kingdom | 9.5% |
| China | 13.2% |
| India | 12.8% |
| Australia | 8.1% |
Some of the leading companies operating in the global ischemic stroke aspiration systems market include Medtronic, Penumbra, Inc., Insera Therapeutics, Imperative Care Inc., and others. Further, the biggies have adopted several main tactics, including increasing manufacturing capacity and developing new products.
A large portfolio of products from other medical device markets and Medtronic's strong presence in the stent retrieval market might prove beneficial to Medtronic in establishing a strong presence in the marketplace. Further, this can also be said for PTA Drug-Eluting Balloons, which Medtronic previously demonstrated in the catheter market.
Medtronic's Riptide system is approved for use with their existing Arc catheter, intracranial support catheters will typically cost less than Penumbra's aspiration catheter; therefore, the lower disposable cost is going to prove advantageous for Medtronic when competing against Penumbra's ACE system.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 9.9% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million, Volume in Kilotons, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available Upon Request |
The global market is expected to be worth US$ 2.8 billion by 2033.
The market is forecast to register a CAGR of 9.9% from 2023 to 2033.
Improving healthcare infrastructure in India is capturing a huge revenue in the global market.
The hospital segment contributes a maximum share of the market.
China is a significantly growing country capturing a CAGR of 13.2%.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
5.3.1. Hospitals
5.3.2. Ambulatory Surgery Centers
5.3.3. Specialty Clinics
5.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Western Europe
6.3.4. Eastern Europe
6.3.5. South Asia and Pacific
6.3.6. East Asia
6.3.7. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. USA.
7.2.1.2. Canada
7.2.2. By End User
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By End User
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By End User
8.4. Key Takeaways
9. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. United Kingdom.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Rest of Western Europe
9.2.2. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By End User
9.4. Key Takeaways
10. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Poland
10.2.1.2. Russia
10.2.1.3. Czech Republic
10.2.1.4. Romania
10.2.1.5. Rest of Eastern Europe
10.2.2. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By End User
10.4. Key Takeaways
11. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Bangladesh
11.2.1.3. Australia
11.2.1.4. New Zealand
11.2.1.5. Rest of South Asia and Pacific
11.2.2. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By End User
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By End User
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By End User
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By End User
14.6. United Kingdom.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By End User
14.10. Poland
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By End User
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By End User
14.12. Czech Republic
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By End User
14.13. Romania
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By End User
14.14. India
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By End User
14.15. Bangladesh
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By End User
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By End User
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By End User
14.18. China
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By End User
14.19. Japan
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By End User
14.20. South Korea
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By End User
14.21. GCC Countries
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2022
14.21.2.1. By End User
14.22. South Africa
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2022
14.22.2.1. By End User
14.23. Israel
14.23.1. Pricing Analysis
14.23.2. Market Share Analysis, 2022
14.23.2.1. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Medtronic
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Penumbra, Inc.
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Insera Therapeutics
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Imperative Care Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Stryker Corporation
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Terumo Corporation
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. MicroVention, Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Phenox GmbH
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Rapid Medical Ltd.
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Acandis GmbH
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Ischemic Stroke Aspiration Systems Market
